Joseph Sheridan

Title: Joseph Sheridan: Innovator in CD200 Mutants

Introduction

Joseph Sheridan is an accomplished inventor based in Oxfordshire, GB. He is known for his significant contributions to the field of biotherapeutics, particularly through his work on CD200 mutants. His innovative approach has the potential to impact various therapeutic applications.

Latest Patents

Joseph Sheridan holds a patent for "CD200 mutants and its uses." This invention relates to mutant CD200 proteins that bind with greater affinity to the CD200 receptor than wild-type CD200. Specifically, the invention focuses on a mutated CD200 protein that includes a mutation at amino acid residue positions 130 and/or 131. Additionally, it encompasses a fusion protein that combines the mutated protein with a non-CD200 protein encoding portion, along with a pharmaceutical composition that includes the defined protein and its various uses.

Career Highlights

Throughout his career, Joseph Sheridan has made notable advancements in the field of biotherapeutics. His work has led to the development of innovative solutions that address critical medical needs. His expertise in protein engineering and therapeutic applications has positioned him as a key figure in his industry.

Collaborations

Joseph has collaborated with esteemed colleagues, including Philip Huxley and Jonathan Heal. These partnerships have fostered a collaborative environment that enhances the research and development of biotherapeutic solutions.

Conclusion

Joseph Sheridan's contributions to the field of biotherapeutics, particularly through his patent on CD200 mutants, highlight his innovative spirit and dedication to advancing medical science. His work continues to pave the way for future developments in therapeutic applications.